1. Introduction {#sec1}
===============

Small ruminant morbillivirus (previously called peste des petits ruminants virus (PPRV)) is one of the most damaging ruminant diseases. It is among the priority diseases indicated in the FAO-OIE Global Framework for the Progressive Control of Transboundary Animal Diseases (GF-TADs) in the 5-year Action Plan \[[@B1], [@B2]\]. PPRV is one of the top ten diseases in sheep and goats that are having a high impact on the poor rural small ruminant farmers \[[@B3]\]. The disease is considered an acute and highly contagious viral disease with a high morbidity and mortality rate in small ruminants, such as goats and sheep and related wild animals \[[@B4], [@B5]\]. The disease is characterized by high fever, depression, anorexia, ocular and nasal discharge, pneumonia, necrosis and ulceration of mucous membranes, and inflammation of the gastrointestinal tract leading to severe diarrhea \[[@B6], [@B7]\]. It causes high death rates in goats and sheep up to 100% and 90%, respectively. However, sheep can be subclinically infected and play a major role in the silent spread of PPRV over large distances and across borders \[[@B1]\]. The disease is widely distributed in Africa, on the Arabian Peninsula, and in the Middle East and Asia \[[@B5], [@B8], [@B9]\]. Morbilliviruses are rapidly inactivated at environmental temperature by solar radiation and desiccation. This indicated that the transmission occurred by direct contact with infected animals or their excretions. Transmission of PPRV occurs primarily by droplet infection but may also occur by ingestion of contaminated feed or water \[[@B6]\].

PPRV is an enveloped single strand of negative sense RNA virus, belonging to the genus Morbillivirus, in the family Paramyxoviridae which is closely related to *rinderpest virus* (RPV), *canine distemper virus* (CDV), and *measles virus* (MeV) \[[@B5], [@B10], [@B11]\]. The genome of morbilliviruses is organized into six transcriptional units encoding six structural proteins. These structural proteins include the nucleoprotein (N protein), matrix protein (M protein), polymerase or large protein (L protein), phosphoprotein (P protein), and two envelope glycoproteins, the haemagglutinin protein (H protein) and the fusion protein (F protein) \[[@B12]--[@B14]\]. The N protein played an important role in the viral life cycle, interacting with both viral and cellular proteins. It also interacted with the viral RNA to form the nucleocapsid structures seen in both the virions and infected cells \[[@B13]\]. The viral L and P proteins interact with the nucleocapsids to form the functional transcription/replication unit of the virion \[[@B13]\]. The C-termini of morbillivirus N proteins also interacted with cellular regulatory proteins such as heat shock protein Hsp72, interferon regulator factor- (IRF-) 3, and a novel cell surface receptor (genetically engineered receptor) \[[@B13]\]. The F protein facilitated the virus penetration of the host cell membrane. This protein is also critical for the induction of an effective protective immune response \[[@B15]\]. The M protein of paramyxoviruses forms an inner coat to the viral envelope and thus serves as a bridge between the surface viral glycoproteins and the ribonucleoprotein core. By virtue of its position, M appeared to play a central role in viral assembly by formation of new virions which were liberated from the infected cell by budding \[[@B16], [@B17]\]. Interaction of the PPRV H and F proteins with the host plasma membrane led to viral entry by binding of the H protein to receptors \[[@B17]\]. Generally, the protective cell-mediated and humoral immune responses against morbilliviruses are directed mainly against H, F, M, and N proteins. Moreover, PPRV is genetically grouped into four distinct lineages (I, II, III, and IV) based on the analysis of the fusion (F) gene. This classification of PPRV into lineages has broadened the understanding of the molecular epidemiology and worldwide movement of PPR viruses \[[@B7], [@B18]--[@B20]\].

Vaccination is the main tool for controlling and eradicating the PPR virus \[[@B12]\]. Despite the fact that live attenuated vaccines have been widely used to protect small ruminants against circulating PPRV \[[@B1], [@B3], [@B7]\], the continuous spread of PPR disease indicated two possible hypotheses. The first is the emergence of new PPRV strains with new genetic makeup and greater fitness in the face of vaccine-elicited protection. The second is the lapses in regulatory control that ultimately lead to movement of diseased/infected individuals across the region/state/country without proper monitoring and surveillance \[[@B1]\].

The advances made in the field of immunoinformatics tools coinciding with the knowledge on the host immune response lead to new disciplines in vaccine design against diseases via computer in silico epitope predictions. The epitope-driven vaccine is a new concept that is being successfully applied in multiple studies, particularly to the development of vaccines targeting conserved epitopes in variable or rapidly mutating pathogens \[[@B21]--[@B23]\]. The identification of specific epitopes derived from infectious disease has significantly advanced the development of peptide-based vaccines. Peptides elicited more desirable manipulation of immune response through the use of the B cell epitopes. These epitopes mainly induce antibody production from B cells and cellular response and cytokine secretion from T cells. The approach regarding the molecular basis of antigen recognition and HLA binding motifs to host class I and class II MHC proteins is highly supported by the immunoinformatics which aids in designing epitope-based vaccine motifs that serve as therapeutic candidates for many infectious diseases \[[@B24]\].

The main objective of this study was to analyze multiple immunogenic proteins from the PPR genome for designing a safe multiepitope vaccine using immunoinformatics tools present in the Immune Epitope Database (IEDB). These proteins include haemagglutinin protein (H), matrix protein (M), fusion protein (F), and nucleoprotein (N) sequences of PPRV strains reported in the (NCBI) database.

2. Materials and Methods {#sec2}
========================

2.1. Sequence Retrieval {#sec2.1}
-----------------------

Four immunogenic protein sequences of PPRV (updated August 2018) were retrieved from GenBank of the National Center for Biotechnology Information (NCBI) (<http://www.ncbi.nlm.nih.gov/protein>) in Oct. 2018. These included 82 sequences from the haemagglutinin protein (H protein), 67 sequences from the matrix protein (M protein), 94 sequences from the fusion protein (F protein), and 80 sequences from the nucleoprotein (N protein). All sequences were retrieved in FASTA format. The retrieved sequences, their accession numbers, and geographical locations are listed in Tables [1](#tab1){ref-type="table"}[](#tab2){ref-type="table"}[](#tab3){ref-type="table"}--[4](#tab4){ref-type="table"}.

2.2. Phylogenetic Evolution {#sec2.2}
---------------------------

A phylogenetic tree of the retrieved sequences of each immunogenic protein was constricted using MEGA7.0.26 (7170509) software \[[@B25]\]. Each protein tree was constructed using the maximum likelihood parameter in the software.

2.3. Multiple Sequence Alignment {#sec2.3}
--------------------------------

The complete protein sequences of each immunogenic protein of PPRV were aligned via BioEdit software (version 7.2.5) to generate a multiple sequence alignment (MSA) with the ClustalW tool \[[@B26]\].

2.4. Epitope Prediction {#sec2.4}
-----------------------

Several immunobioinformatics tools were used for prediction of multiple epitopes from the four immunogenic proteins of PPRV. Tools from the Immune Epitope Database analysis resource (<http://www.iedb.org/>) \[[@B27]\] were used to analyze the immunogenic proteins. The input was the reference sequences of H protein (YP_133827.2), M protein (YP_133825.1), F protein (YP_133826.1), and N protein (YP_133821.1). They were submitted to Epitope Analysis Resources to predict B and T cell epitopes. The predicted epitopes were further investigated in aligned retrieved sequences for conservancy to identify the proposed candidate epitopes.

### 2.4.1. B Cell Epitope Prediction {#sec2.4.1}

Epitopes that interacted with the B lymphocytes are a discrete part from the antigenic molecule that is recognized by the B cell receptor and elicited immunoglobulin production. These predicted epitopes are characterized by their surface accessibility and their antigenic reactivity with the immunoglobulins of the humoral immunity \[[@B24]\]. Epitope prediction tools of the Immune Epitope Database (IEDB) at <http://tools.iedb.org/bcell/> \[[@B27]\] were used for this purpose. Linear B cell epitopes were predicted by BepiPred linear epitope prediction (<http://tools.iedb.org/bcell/result/>) \[[@B28]\]. The Emini surface accessibility prediction tool was performed to detect the surface accessible epitopes (<http://tools.iedb.org/bcell/>) \[[@B29]\], while prediction of antigenic epitopes was performed to identify the antigenic determinants on proteins based on the physicochemical properties of amino acid residues using the Kolaskar and Tongaonkar antigenicity method (<http://tools.immuneepitope.org/bcell/>) \[[@B30]\].

### 2.4.2. Cytotoxic T Lymphocyte Epitope Prediction {#sec2.4.2}

IEDB tools (<http://tools.iedb.org/mhci/>) were used to predict different cytotoxic T cell (CTL) epitopes that bind to the major histocompatibility complex class I alleles (MHC class I) \[[@B31]\]. Analysis was done using cow alleles (BoLA-D18.4, BoLA-HD6, BoLA-JSP.1, BoLA-T2a, BoLA-T2b, and BoLA-T2c). An artificial neural network (ANN) was used to predict the binding affinity \[[@B32], [@B33]\]. The peptide length for all selected epitopes was set to 9 amino acids (9mers). Percentile rank required for the peptide\'s binding to the specific MHC-I molecules was set in the range from 1 to 3.

2.5. Homology Modeling {#sec2.5}
----------------------

### 2.5.1. The Three-Dimensional (3D) Structures of the Reference Sequences of PPRV {#sec2.5.1}

The prediction of the three-dimensional (3D) structure of H, M, and F protein reference sequences of PPRV was performed using the RaptorX structure prediction server (<http://raptorx.uchicago.edu/StructurePrediction/predict/>) \[[@B34]--[@B36]\], while the N protein sequence was submitted to the SPARKS-X server (<http://sparks-lab.org/yueyang/server/SPARKS-X/>) \[[@B37]\]. The 3D structure of each protein reference sequence was later treated with Chimera software 1.8 to show the position of proposed epitopes \[[@B38]\].

3. Results and Discussion {#sec3}
=========================

The validity and benefits of peptide vaccines designed by bioinformatics tools had been verified by appreciable research \[[@B24]\]. The availability of the complete genome, proteome sequences, and pathogenesis of many pathogenic microorganisms contributed to the production of a vaccine through bioinformatics \[[@B24], [@B39]\]. In this study, the predicted epitopes from B and T lymphocytes would help in the development of a more effective, reliable, preventive, and therapeutic vaccine against the PPRV than the conventional methods.

3.1. Phylogenetic Evolution {#sec3.1}
---------------------------

A phylogenetic tree was constructed using MEGA7.0.26 (7170509). The evolutionary divergence among each protein was analyzed. As shown in [Figure 1](#fig1){ref-type="fig"}, the retrieved strains of the H protein revealed that Asian strains were clustered together as well as the European and African strains. However, strains from the United Arab Emirates and Oman were closely related to African strains (namely to Ethiopian strains). With regard to the phylogeny of the M protein strains, the African strains were also clustered together, but among them, the Oman and United Arab Emirates strains were observed to be close to the Ethiopian strains same as those of the H protein. This result may indicate the transfer of the H and M strain segments between these countries. Also, some European and Turkish strains were clustered together. As shown in [Figure 2](#fig2){ref-type="fig"}, the retrieved strains of F and N proteins from the Asian strains were clustered together with molecular divergence among them as well as the strains retrieved from the African countries. Also, the Omanis and Emiratis strains showed close relationship to the African strains. These results indicated that these strain segments were widely distributed in Africa, Asia, Europe, and the Arab region.

3.2. Sequence Alignment {#sec3.2}
-----------------------

Multiple sequence alignment was performed using ClustalW in BioEdit software. As shown in [Figure 3](#fig3){ref-type="fig"}, the aligned sequences of each of the four analyzed proteins (H, M, F, and N proteins) showed considerable conservancy among the retrieved strains. However, some regions exhibited differences (mutations) in some amino acids in various sequences.

3.3. Prediction of B Cell Epitopes {#sec3.3}
----------------------------------

B cell epitope prediction methods aimed are at identifying the antigens recognized by B lymphocytes to initiate humoral immunity \[[@B24]\]. The important criteria for selecting a potential epitope for vaccine development are surface accessibility, hydrophobicity, flexibility, and antigenicity \[[@B40]\]. The predicted epitopes should be located on the surface of the cells so that it is more accessible for both the humoral and the cellular immune systems. Antigenicity also is one of the important features of an antigen for vaccine development \[[@B40]\]. Depending on binding affinity to B lymphocytes, the BepiPred linear epitope prediction method predicted nine linear epitopes from the H protein, eight epitopes from M proteins, and ten epitopes for each of the F and N proteins. Analysis of these linear epitopes for surface accessibility proposed seven surface epitopes from each of the H and F proteins, six epitopes from the M protein, and four epitopes from the N protein.

As shown in [Figure 4](#fig4){ref-type="fig"}, the threshold values were 0.350 and 1.000 for all epitopes predicted through the BepiPred linear epitope (conserved epitopes) and Emini prediction methods (surface accessibility), respectively. The antigenicity prediction method proposed only two epitopes for all test immunogenic proteins of PPRV. Also, [Figure 4](#fig4){ref-type="fig"} shows that the antigenic epitopes were predicted from H, M, F, and N proteins using the Kolaskar and Tongaonkar antigenicity method under threshold values of 1.014, 1.037, 1.054, and 1.014, respectively. However, no epitopes successfully passed the threshold for the F and N proteins.

Only one epitope from each of the H and M proteins successfully overlapped all the B cell antigenic index prediction methods. Namely, these epitopes were *~142~PPERV~146~* from the H protein and *~63~DPLSP~67~* from the M protein. The 3D structure of the four proteins (H, M, F, and N) is shown in [Figure 5](#fig5){ref-type="fig"}. The positions of the best B cells that predicted epitopes from the H and M proteins are demonstrated in [Figure 6](#fig6){ref-type="fig"}. The overall predicted epitopes from the four proteins are illustrated in [Table 5](#tab5){ref-type="table"}.

3.4. Prediction of CTL Epitopes That Interacted with MHC Class I (BoLA Alleles) {#sec3.4}
-------------------------------------------------------------------------------

CD8+ and CD4+ T cells have a principal role in the stimulation of immune response as well as antigen-mediated clonal expression of the B cell \[[@B14]\]. Unfortunately, the bovine genome project did not assemble a complete sequence of the bovine MHC-II locus \[[@B41]--[@B43]\]. Thus, the analysis was completed with BoLA MHC-I alleles only. Cell-mediated immunity induced by cytotoxic T lymphocytes (CTLs) is vital for the defense against viral diseases. CTLs are responsible for the immune elimination of intracellular pathogens such as viruses because these cells recognize the presented endogenous antigenic peptides by the MHC class I molecules \[[@B44]\].

In this study, MHC-I binding prediction methods using the IEDB database predicted different CTL epitopes that strongly interacted with various BoLA alleles. The fusion (F) protein proposed a higher number of predicted epitopes with strong interaction with BoLA alleles. Ten epitopes were proposed based on the number of the interacted alleles. The best one was *~358~STKSCARTL~366~* that associated with five alleles, followed by *~442~IDLGPAISL~450~* and *~340~SQNALYPMS~348~* as they linked to three alleles each. However, seven epitopes, namely, *~339~CSQNALYPMS~347~*, *~336~GTVCSQNAL~344~*, *~279~IAYPTLSEI~287~*, *~230~LSYALGGDI~238~*, *~136~SLMNSQAIE~144~*, *~283~TLSEIKGVI~291~*, and *~314~YVATQGYLI~322~* were predicted to interact with two alleles.

The nucleoprotein (N) also displayed strong interaction activity with BoLA alleles. Seven epitopes were proposed with strong interaction with BoLA alleles. The top N protein epitope was *~490~RSAEALFRL~498~* which was associated with five alleles, followed by two epitopes, namely, ~2~*ATLLKSLAL*~10~, and *~304~QQLGEVAPY~312~* that linked to four alleles each. In addition to that, four epitopes *~3~TLLKSLALF~11~*, *~356~YFDPAYFRL~364~*, *~360~AYFRLGQEM~368~*, and *~412~PRQAQVSFL~420~* interacted with three bovine alleles each. Surprisingly, these two proteins (F and N) achieved promising results in CTL prediction methods, although they failed to predict any epitope carrying all the ideal traits in B cells.

The haemagglutinin (H) protein predicted five CTL epitopes, but one epitope was predicted as the best peptide, *~45~MFLSLIGLL~53~*, as it linked to four BoLA alleles, followed by four peptides that interacted with two alleles each. They were *~113~DLVKFISDK~121~*, *~405~GRIPAYGVI~413~*, *~52~LLAIAGIRL~60~*, and *~44~VMFLSLIGL~52~*. However, this protein showed a somewhat satisfactory result in B and T cell prediction methods. The M protein showed unsatisfactory results in CTL prediction methods different from that predicted by B cell methods. The results suggested only one epitope; *~276~FKKILCYPL~284~* interacted with only two alleles. The overall epitopes that were proposed to interact with CTL alleles are illustrated in [Table 6](#tab6){ref-type="table"} for all proteins. The positions of the best CTL-predicted epitopes in their immunogenic protein structure are shown in [Figure 7](#fig7){ref-type="fig"}.

Vaccination is considered the most effective way of controlling PPR. The infection by morbillivirus is associated with severe immunosuppression that is characterized by a massive virus-specific immune response. Protection is mediated by cell-mediated and humoral immune responses directed mainly against particular proteins in the viral structure. These proteins included H, F, and N proteins \[[@B45]--[@B47]\]. It was reported that the envelope glycoproteins H and F of PPRV demonstrated a protective and neutralizing antibody response \[[@B3], [@B48]--[@B50]\]. In this study, using the immunoinformatics prediction methods, the H protein demonstrated affinity to interact with B cells that was characterized by antibody production. This result coincided with the previously published reports \[[@B3], [@B48]--[@B50]\], while the F protein failed to interact with B cells; i.e., no epitopes from the F protein had passed the threshold of the B cell prediction methods. However, this protein revealed multiple predicted epitopes that demonstrated high affinity to the alleles of CTLs. The M protein which is believed to play a very significant role in morbillivirus assembly and budding by concentrating the F, H, and N proteins at the virus-assembly site \[[@B16], [@B17]\] showed moderate affinity to B cells. One epitope from the M protein as well as the H protein was predicted as a B cell epitope. Moreover, the M protein revealed multiple epitopes that interacted with CTLs of the cell-mediated immunity. This result indicated that the M protein besides its role in the virus assembly may also contain antigenic determinants that could be elected as vaccine candidates.

In addition to that, cell-mediated immunity plays a role in protection against the viral infection. Despite the N protein being the most frequent viral protein in PPRV, it does not induce a neutralizing antibody response in the host \[[@B50]\]. However, it has been found to induce a strong cell-mediated immune response, which is believed to contribute to protection. Here, in this report, the same result was obtained. The N protein demonstrated no affinity to elicit the humoral immune response. However, it showed favorable affinity to interact with a cell-mediated response. It is noteworthy that five out of seven epitopes predicted from the nucleoprotein of PPRV in this study were found to be proposed by another *in silico* study using mouse alleles and NetMHCI methods \[[@B51]\]. The proposed epitopes from that study were *ATLLKSLAL*, *TLLKSLALF*, *YFDPAYFRL*, *AYFRLGQEM*, and *RSAEALFRL*. Thus, the predictions for the different epitopes that bound to different alleles particularly from the N protein of PPRV were somewhat in agreement regardless of the alleles (cow and mouse alleles) and algorithm used (ANN, NetMHCI).

In general, epitope-based vaccines that are chemically well-characterized have become desirable candidate vaccines due to their relative ease of production and construction, chemical stability, and lack of infectious potential \[[@B52]\]. Many *in silico* studies have shown the value of using prediction programs to evaluate the efficiency of binding of putative epitopes to various human and animal alleles \[[@B33], [@B52]--[@B55]\].

4. Conclusion {#sec4}
=============

This study focused mainly on the production of a peptide vaccine against H, M, F, and N proteins of PPRV using immunoinformatics tools. Epitopes that showed conservancy and high binding affinities to many MHC alleles are considered the best candidates for *in vitro* and *in vivo* testing. Epitopes that were predicted from B cell prediction methods like *~142~PPERV~146~* and *~305~TVTL~308~* from the H protein and *~63~DPLSP~67~* and *~64~PLSP~67~* from the M protein could act as good B cell epitopes to induce humoral immunity. While the F and N proteins failed to fulfill all B cell indexes used in this study for the prediction of promising epitopes, however, these proteins predicted epitopes that interacted with various BoLA MHC-I alleles. For instance, the best epitopes were predicted from F (*~358~STKSCARTL~366~*) and N (*~490~RSAEALFRL~498~*) proteins as they interacted with five MHC-I BoLA alleles, followed by *~45~MFLSLIGLL~53~* proposed from the H protein and linked with four alleles, while the *~276~FKKILCYPL~284~* epitope was predicted from the M protein linked with only two alleles. Although bioinformatics studies have been established to facilitate the peptide design, not all peptides that are predicted *in silico* are optimally immunogenic *in vivo* and it remains necessary to test the expected peptides *in vivo* to ensure that the T cell responses are elicited.
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![Phylogenetic tree of retrieved strains of H and M proteins. The retrieved strains demonstrated divergence in their common ancestors.](JIR2019-6124030.001){#fig1}

![Phylogenetic tree of retrieved strains of F and N proteins. The retrieved strains demonstrated divergence in their common ancestors.](JIR2019-6124030.002){#fig2}

![Multiple sequence alignment (MSA) of the retrieved strains of H, M, F, and N proteins using BioEdit software and ClustalW. Dots indicate the conservancy of the retrieved strains, and letters within the aligned sequences indicate no conservancy (mutation) in the amino acid.](JIR2019-6124030.003){#fig3}

![Prediction of B cell epitopes by different IEDB scales (BepiPred linear epitope prediction, Emini surface accessibility, and Kolaskar and Tongaonkar antigenicity prediction) for H, M, F, and N proteins. Regions above the threshold (red line) were proposed as a part of the B cell epitope while regions below the threshold (red line) were not.](JIR2019-6124030.004){#fig4}

![The prediction of the three-dimensional (3D) structure of H, M, and F protein reference sequences of PPRV was performed using the RaptorX structure prediction server, while the N protein sequence was submitted to the SPARKS-X server.](JIR2019-6124030.005){#fig5}

![The positions of the proposed B cell epitopes in the 3D structure of the reference sequences of PPRV H and M proteins.](JIR2019-6124030.006){#fig6}

![The positions of the predicted T cell epitopes in the 3D structure of the reference sequences of PPRV H, M, F, and N proteins.](JIR2019-6124030.007){#fig7}

###### 

Retrieved strains of the H protein of PPRV with their date of collection, accession numbers, and geographical regions.

  No.   Accession number   Country          Year   No.   Accession number   Country          Year   No.   Accession number   Country   Year
  ----- ------------------ ---------------- ------ ----- ------------------ ---------------- ------ ----- ------------------ --------- ------
  1     AEH25644           China            2011   29    ATS17278           Sierra Leone     2017   57    ASN64042           China     2017
  2     ABY71271           China            2008   30    AMX28327           India            2017   58    ASN64036           China     2017
  3     AAS68031           India            2009   31    AMX28319           India            2017   59    ASN64030           China     2017
  4     ABX75304           Cote d\'Ivoire   2008   32    AMX28311           India            2017   60    ASN64024           China     2017
  5     ABX75312           Nigeria          2008   33    ANS54233           Liberia          2016   61    ASN64018           China     2017
  6     ADM32488           India            2012   34    AKT04315           Benin            2016   62    ASN64012           China     2017
  7     AEX61013           India            2012   35    AKT04307           Benin            2016   63    ASN64006           China     2017
  8     ASY05923           Georgia          2017   36    AKR81281           India            2015   64    ASN64000           China     2017
  9     ARB50221           China            2017   37    AKT04323           Cote d\'Ivoire   2015   65    ASN63994           China     2017
  10    ANS59483           India            2016   38    AJT59441           Senegal          2015   66    ASN63988           China     2017
  11    AKQ09544           India            2015   39    AID07002           Ghana            2015   67    ASN63982           China     2017
  12    AIL54036           UAE              2014   40    AIN40492           Kenya            2014   68    ASN63976           China     2017
  13    AIL54028           Oman             2014   41    AHG50444           India            2014   69    ASN63970           China     2017
  14    AIL54020           Uganda           2014   42    ACQ44671           China            2011   70    ASN63964           China     2017
  15    AIL53996           Ethiopia         2014   43    ABY61988           India            2008   71    ASN63867           China     2017
  16    AIL54012           India            2014   44    ABY61986           India            2008   72    ASN63861           China     2017
  17    AIL54004           Ethiopia         2014   45    CAH61258           Turkey           2005   73    ASN63855           China     2017
  18    CAD54790           India            2004   46    ANG60369           Nigeria          2016   74    ASN63849           China     2017
  19    AHA58209           Iraq             2018   47    ANG60361           Nigeria          2016   75    ART66998           Algeria   2017
  20    ARP51875           Mongolia         2018   48    AJE30413           China            2015   76    ALM55670           China     2016
  21    AOO35467           China            2018   49    AJE30404           China            2015   77    ALA65398           China     2015
  22    AIL29370           Turkey           2014   50    AUP34040           Nigeria          2018   78    AKN58853           China     2015
  23    AGG09146           Morocco          2014   51    ASN64078           China            2015   79    AJA39814           China     2015
  24    ADN03213           India            2013   52    ASN64072           China            2017   80    AIK97759           China     2014
  25    ACN62119           India            2015   53    ASN64066           China            2017   81    AIK19904           Senegal   2014
  26    CAJ01700           Nigeria          2005   54    ASN64060           China            2017   82    ADX95995           Nigeria   2011
  27    YP_133827          Turkey           2018   55    ASN64054           China            2017                                      
  28    AUO30190           Bangladesh       2018   56    ASN64048           China            2017                                      

###### 

Retrieved strains of the matrix protein of PPRV with their date of collection, accession numbers, and geographical regions.

  No.   Accession number   Country    Year   No.   Accession number   Country          Year   No.   Accession number   Country          Year
  ----- ------------------ ---------- ------ ----- ------------------ ---------------- ------ ----- ------------------ ---------------- ------
  1     YP_133825          Turkey     2018   24    APX56396           Mali             2013   47    AIL54018           Uganda           2014
  2     ANS54231           Liberia    2016   25    APX56395           Senegal          2015   48    AIL54010           India            2014
  3     AKT04313           Benin      2016   26    APX56394           Comoros          2005   49    AIL53994           Ethiopia         2014
  4     AKT04305           Benin      2016   27    APX56393           Mali             2018   50    AIL54002           Ethiopia         2014
  5     AMX28325           India      2017   28    APX56392           Mali             2018   51    AGO28147           India            2013
  6     AMX28317           India      2017   29    APX56391           Mali             2018   47    AIL54018           Uganda           2014
  7     ANS59481           India      2016   30    APX56390           Algeria          2018   52    AGG09144           Morocco          2013
  8     AKR81279           India      2015   31    APX56389           Guinea           2018   53    AEH25642           China            2011
  9     CAJ01698           Nigeria    2005   32    APX56388           Mauritania       2018   54    ACQ44669           China            2011
  10    ADN03215           India      2015   33    APX56387           Senegal          2018   55    ABY61987           India            2008
  11    ADN03212           India      2012   34    APX56386           Senegal          2018   56    ABY61985           India            2008
  12    ADM32486           India      2012   35    AUO30188           Bangladesh       2018   57    CAH61256           Turkey           2005
  13    ACN62117           India      2012   36    ATS17276           Sierra Leone     2017   58    AOO35465           China            2016
  14    AEX61011           India      2012   37    ASY05921           Georgia          2017   59    ABX75310           Nigeria          2008
  15    AWD71674           Pakistan   2018   38    ARP51873           Mongolia         2017   60    ABX75302           Cote d\'Ivoire   2008
  16    AWD71668           Pakistan   2018   39    AKQ09542           India            2015   61    AUP34038           Nigeria          2018
  17    AWD71662           Pakistan   2018   40    AKT04321           Cote d\'Ivoire   2015   62    ART66996           Algeria          2017
  18    AMX28309           India      2017   41    AJT59439           Senegal          2015   63    AIK19902           Senegal          2014
  19    APX56401           Senegal    2018   42    AKG94167           India            2015   64    ADX95993           Nigeria          2011
  20    APX56400           Senegal    2018   43    AID07000           Ghana            2015   65    AAS68029           India            2009
  21    APX56399           Senegal    2018   44    AIN40490           Kenya            2014   66    ANG60367           Nigeria          2016
  22    APX56398           Senegal    2014   45    AIL54034           UAE              2014   67    ANG60359           Nigeria          2016
  23    APX56397           Senegal    2014   46    AIL54026           Oman             2014                                             

###### 

Retrieved strains of the fusion protein of PPRV with their date of collection, accession numbers, and geographical region.

  No.   Accession number   Country          Year   No.   Accession number   Country    Year   No.   Accession number   Country   Year
  ----- ------------------ ---------------- ------ ----- ------------------ ---------- ------ ----- ------------------ --------- ------
  1     YP_133821          Turkey           2018   28    AMQ48343           China      2016   55    AFC87747           Nigeria   2012
  2     AIN40487           Kenya            2014   29    AMQ48342           China      2016   56    AFC87741           Nigeria   2012
  3     AYA72170           India            2018   30    AKQ09546           India      2015   57    AFC87740           Nigeria   2012
  4     AYA72169           India            2018   31    AKG94165           India      2015   58    AFC87739           Nigeria   2012
  5     AYA72168           India            2018   32    AIL54030           UAE        2014   59    ABZ81035           China     2008
  6     AYA72167           India            2018   33    AIL54022           Oman       2014   60    AEX61010           India     2012
  7     ACN62116           India            2012   34    AIL54014           Uganda     2014   61    AEH25639           China     2011
  8     ACN62115           India            2012   35    AIL53990           Ethiopia   2014   62    ACQ44667           China     2011
  9     AUO30184           Bangladesh       2018   36    AIL54006           India      2014   63    CAH61252           Turkey    2005
  10    AUB45018           China            2017   37    AIL53998           Ethiopia   2014   64    CAD91555           Turkey    2003
  11    ATS17282           Sierra Leone     2017   38    AGJ84027           Morocco    2013   65    CAA52454           Nigeria   2005
  12    ANS54228           Liberia          2016   39    AFC87764           Nigeria    2012   66    AMX28321           India     2017
  13    AKT04301           Benin            2016   40    AFC87763           Nigeria    2012   67    AMX28313           India     2017
  14    AKT04317           Cote d\'Ivoire   2015   41    AFC87762           Nigeria    2012   68    AMX28305           India     2017
  15    AJT59435           Senegal          2015   42    AFC87761           Nigeria    2012   69    ANS59477           India     2016
  16    ABX75299           Cote d\'Ivoire   2008   43    AFC87760           Nigeria    2012   70    AKT04309           Benin     2016
  17    ABY61984           India            2008   44    AFC87759           Nigeria    2012   71    AKR81275           India     2015
  18    ABX75307           Nigeria          2008   45    AFC87758           Nigeria    2012   72    AGG09141           Morocco   2013
  19    ART66992           Algeria          2017   46    AFC87757           Nigeria    2012   73    ADJ05523           China     2010
  20    APD77391           China            2016   47    AFC87756           Nigeria    2012   74    AAS68026           India     2009
  21    ADN03214           India            2012   48    AFC87755           Nigeria    2012   75    ANG60363           Nigeria   2016
  22    ADN03211           India            2012   49    AFC87754           Nigeria    2012   76    ANG60355           Nigeria   2016
  23    ADM32485           India            2012   50    AFC87753           Nigeria    2012   77    AUP34034           Nigeria   2018
  24    ASY05917           Georgia          2017   51    AFC87752           Nigeria    2012   78    AIK19898           Senegal   2014
  25    ARP51869           India            2017   52    AFC87750           Nigeria    2012   79    ADX95989           Nigeria   2011
  26    AOO35463           China            2017   53    AFC87749           Nigeria    2012   80    AID07004           Ghana     2015
  27    AMQ48344           China            2016   54    AFC87748           Nigeria    2012                                      

###### 

Retrieved strains of the nucleoprotein of PPRV with their date of collection, accession numbers, and geographical regions.

  No.   Accession number   Country   Year   No.   Accession number   Country          Year   No.   Accession number   Country          Year
  ----- ------------------ --------- ------ ----- ------------------ ---------------- ------ ----- ------------------ ---------------- ------
  1     AHA58208           Iraq      2018   33    ASN63969           China            2017   65    AIL54019           Uganda           2014
  2     AOO35466           China     2016   34    ASN63963           China            2017   66    AIL53995           Ethiopia         2014
  3     AGJ84028           Morocco   2013   35    ASN63872           China            2017   67    AIK97758           China            2014
  4     CAJ01699           Nigeria   2005   36    ASN63866           China            2017   68    AIK19903           Senegal          2014
  5     AHN53450           India     2014   37    ASN63860           China            2017   69    AIL54011           India            2014
  6     ADN03216           India     2012   38    ASN63854           China            2017   70    AIL54003           Ethiopia         2014
  7     ADM32487           India     2012   39    ASN63848           China            2017   71    AHG50445           India            2014
  8     ACN62118           India     2012   40    ARP51874           Mongolia         2017   72    AGP04219           Bangladesh       2013
  9     AEX61012           India     2012   41    AMX28326           India            2017   73    AGG09145           Morocco          2013
  10    ADX95994           Nigeria   2011   42    AMX28318           India            2017   74    AFR66765           China            2012
  11    YP_133826          Turkey    2017   43    AMX28310           India            2017   75    ACV31220           India            2012
  12    ATS17277           Sierra    2017   44    APD77392           China            2016   76    ACV31219           India            2012
  13    ASY05922           Georgia   2017   45    ANS59482           India            2016   77    ACQ44670           China            2011
  14    ASV72322           China     2017   46    AHF58487           India            2016   78    ADJ05518           China            2010
  15    ASN64077           China     2017   47    ALM55669           China            2016   79    CAH61257           Turkey           2005
  16    ASN64071           China     2017   48    AKT04314           Benin            2016   80    AXE28383           Israel           2018
  17    ASN64065           China     2017   49    AKT04306           Benin            2016   81    AWD71675           Pakistan         2018
  18    ASN64059           China     2017   50    ALA65397           China            2015   82    AWD71669           Pakistan         2018
  19    ASN64053           China     2017   51    AKN58852           China            2015   83    AWD71663           Pakistan         2018
  20    ASN64047           China     2017   52    AKR81280           India            2015   84    AUP34039           Nigeria          2018
  21    ASN64041           China     2017   53    AKQ09543           India            2015   85    AUO30189           Bangladesh       2018
  22    ASN64035           China     2017   54    AKT04322           Cote d\'Ivoire   2015   86    ANG60368           Nigeria          2016
  23    ASN64029           China     2017   55    AJT59440           Senegal          2015   87    ANG60360           Nigeria          2016
  24    ASN64023           China     2017   56    AKG94168           India            2015   88    ANS54232           Liberia          2016
  25    ASN64017           China     2017   57    AJA39813           China            2015   89    ART66997           Algeria          2017
  26    ASN64011           China     2017   58    AID07001           Ghana            2015   90    ABX75303           Cote d\'Ivoire   2008
  27    ASN64005           China     2017   59    AJE30412           China            2015   91    ABX75311           Nigeria          2008
  28    ASN63999           China     2017   60    AJE30403           China            2015   92    ABY71270           China            2008
  29    ASN63993           China     2017   61    AJE30396           China            2015   93    AAS68030           India            2009
  30    ASN63987           China     2017   62    AIN40491           Kenya            2014   94    AEH25643           China            2011
  31    ASN63981           China     2017   63    AIL54035           UAE              2014                                             
  32    ASN63975           China     2017   64    AIL54027           Oman             2014                                             

###### 

B cell epitope prediction from H, M, F, and N proteins; the position of peptides is according to the position of amino acids in the protein of the PPR virus.

  ----------- ------------------ ------- ----- -------- ------------- ----------------
  H protein   Peptide            Start   End   Length   Emini 1.000   Kolaskar 1.041
  1           PHNK               16      19    4        2.683         0.969
  2           SIDHQ              83      87    5        1.169         1.03
  3           PPERV^\#^          142     146   5        1.904         1.047
  4           TVTL               305     308   4        0.505         1.113
  5           TLGG               330     333   4        0.462         0.977
  6           EANWVVPSTDVRDLQ    362     376   15       1.022         1.039
  7           KTRPPSFCNGTG       387     398   12       1.314         0.982
  8           GPWSEGRIP          400     408   9        1.023         0.962
  9           DVSR               530     533   4        1.29          1.034
                                                                      
  M protein   Peptide            Start   End   Length   Emini 1.000   Kolaskar 1.037
  1           SAWDV              10      14    5        0.533         1.044
  2           GDRK               43      46    4        2.478         0.886
  3           EDNDPLSP^∗^        60      67    8        3.167         0.969
  4           DPLSP^∗\#^         63      67    5        1.332         1.051
  5           VGRT               69      72    4        0.795         1.01
  6           PEEL               87      90    4        1.464         1.004
  7           DNGYYS^∗^          167     172   6        2.116         0.975
  8           INDD               325     328   4        1.203         0.915
                                                                      
  F protein   Peptide            Start   End   Length   Emini 1.000   Kolaskar 1.054
  1           TGSA               34      37    4        0.867         0.965
  2           SNQA               153     156   4        1.691         0.967
  3           SLRDP              216     220   5        2.058         1.013
  4           QEWYT              305     309   5        2.625         0.966
  5           VFTP               331     334   4        0.643         1.112
  6           GTVC               336     339   4        0.255         1.144
  7           GSTKS              357     361   5        1.888         0.947
  8           QDPDK              402     406   5        5.498         0.948
  9           VGSREYPD           428     435   8        2.837         1.01
  10          LKPDLTGTSKS        531     541   11       3.269         0.996
                                                                      
  N protein   Peptide            Start   End   Length   Emini 1.000   Kolaskar 1.014
  1           DKAPTASGSGGAI^∗^   16      28    13       0.249         0.981
  2           IPGDSSI            39      45    7        0.345         1.019
  3           GDPDINGS           60      67    8        0.735         0.935
  4           TDDPDV             92      97    6        1.569         0.992
  5           STRSQS             107     112   6        2.397         0.972
  6           GADLD^∗^           120     124   5        0.619         0.984
  7           VTAPDTAADS         182     191   10       0.594         1.02
  8           RTPGNKPR           242     249   8        4.853         0.92
  9           KFSA               323     326   4        0.83          1.024
  10          RGTGPRQA^∗^        408     415   8        1.69          0.943
  ----------- ------------------ ------- ----- -------- ------------- ----------------

^∗^Peptides revealed a higher score if they were shortened in all tools. ^\#^Epitopes that passed all the B cell prediction methods and were proposed as B cell epitopes.

###### 

Position of CTL epitopes in the H protein, M protein, F protein, and N protein of PPRV that bind with high affinity with the BoLA class I alleles.

  ------------ ----------- ------- ------------ ------------ -----------------
               Peptide     Start   End          Allele       Percentile rank
  H protein    DLVKFISDK   113     121          BoLA-T2a     2
  BoLA-T2C     1.9                                           
  FLRVFEIGL    251         259     BoLA-HD6     1            
  GRIPAYGVI    405         413     BoLA-D18.4   2.3          
  BoLA-T2b     2.1                                           
  LLAIAGIRL    52          60      BoLA-HD6     1.5          
  BoLA-T2b     2.3                                           
  LSLIGLLAI    47          55      BoLA-T2a     2.9          
  LVKFISDKI    114         122     BoLA-HD6     1.3          
  MFLSLIGLL    45          53      BoLA-HD6     2.1          
  BoLA-JSP.1   1.7                                           
  BoLA-T2b     1.4                                           
  BoLA-T2C     1.7                                           
  VMFLSLIGL    44          52      BoLA-JSP.1   2.6          
  BoLA-T2C     1.7                                           
  WCYHDCLIY    578         586     BoLA-T2a     1.2          
  WSEGRIPAY    402         410     BoLA-JSP.1   2.2          
                                                             
  M protein    SAWDVKGSI   10      18           BoLA-HD6     1.8
  EELLREATE    88          96      BoLA-T2b     1            
  ELLREATEL    89          97      BoLA-HD6     1.3          
  PQRFRVVYM    152         160     BoLA-JSP.1   1.7          
  HVGNFRRKK    220         228     BoLA-T2a     2.4          
  GGIGGTSLH    251         259     BoLA-T2a     2            
  LHAQLGFKK    270         278     BoLA-T2a     1.2          
  AQLGFKKIL    272         280     BoLA-T2C     2.4          
  FKKILCYPL    276         284     BoLA-D18.4   1.2          
  BoLA-HD6     1.3                                           
  EFRVYDDVI    316         324     BoLA-HD6     2.6          
                                                             
  F protein    AGVALHQSL   129     137          BoLA-T2C     1.7
  ASVLCKCYT    387         395     BoLA-T2a     1.4          
  AYPTLSEIK    280         288     BoLA-T2a     2.9          
  CSQNALYPM    339         347     BoLA-JSP.1   2.3          
  BoLA-T2a     2.5                                           
  DETSCVFTP    326         334     BoLA-T2b     2.7          
  DLGPAISLE    443         451     BoLA-T2C     1.3          
  EKLDVGTNL    451         459     BoLA-T2b     2.7          
  GSTKSCART    357         365     BoLA-T2a     2.6          
  GTVCSQNAL    336         344     BoLA-JSP.1   2.5          
  BoLA-T2b     1.6                                           
  GVALHQSLM    130         138     BoLA-HD6     2.1          
  IAYPTLSEI    279         287     BoLA-HD6     2.9          
  BoLA-JSP.1   2.3                                           
  IDLGPAISL    442         450     BoLA-D18.4   2.1          
  BoLA-T2b     1.4                                           
  BoLA-T2C     1.2                                           
  IQALSYALG    227         235     BoLA-T2b     2.7          
  IQVGSREYP    426         434     BoLA-D18.4   2.8          
  KGIKARVTY    259         267     BoLA-D18.4   1.2          
  KPDLTGTSK    532         540     BoLA-T2a     2.6          
  LEKLDVGTN    450         458     BoLA-T2b     3            
  LIANCASVL    382         390     BoLA-HD6     1.6          
  LSKGNLIAN    377         385     BoLA-T2a     3            
  LSYALGGDI    230         238     BoLA-HD6     1.8          
  BoLA-JSP.1   1.2                                           
  NALYPMSPL    342         350     BoLA-T2b     1.5          
  PMSPLLQEC    346         354     BoLA-T2C     3            
  RFILSKGNL    374         382     BoLA-T2b     2            
  SIQALSYAL    226         234     BoLA-T2b     1            
  SLMNSQAIE    136         144     BoLA-D18.4   3            
  BoLA-T2C     2.5                                           
  SQNALYPMS    340         348     BoLA-D18.4   2.7          
  BoLA-HD6     1.7                                           
  BoLA-D18.4   2.3                                           
  STKSCARTL    358         366     BoLA-D18.4   3            
  BoLA-HD6     2.7                                           
  BoLA-JSP.1   1.6                                           
  BoLA-T2b     2.9                                           
  BoLA-T2C     2.7                                           
  TGTSKSYVR    536         544     BoLA-T2a     2.9          
  TKSCARTLV    359         367     BoLA-D18.4   2.3          
  TLSEIKGVI    283         291     BoLA-D18.4   2.4          
  BoLA-T2C     1.8                                           
  YVATQGYLI    314         322     BoLA-HD6     2            
  BoLA-T2C     2.8                                           
                                                             
  N protein    ATLLKSLAL   2       10           BoLA-D18.4   1.6
  BoLA-JSP.1   1.3                                           
  BoLA-T2a     2.6                                           
  BoLA-T2b     1.9                                           
  TLLKSLALF    3           11      BoLA-D18.4   2.6          
  BoLA-HD6     3                                             
  BoLA-T2C     1.3                                           
  QQLGEVAPY    304         312     BoLA-HD6     2.2          
  BoLA-JSP.1   3                                             
  BoLA-T2a     1.4                                           
  BoLA-T2b     2.9                                           
  YFDPAYFRL    356         364     BoLA-JSP.1   1.3          
  BoLA-T2b     2.4                                           
  BoLA-T2C     1.5                                           
  AYFRLGQEM    360         368     BoLA-HD6     1.6          
  BoLA-JSP.1   2.1                                           
  BoLA-T2C     2.9                                           
  PRQAQVSFL    412         420     BoLA-JSP.1   1.7          
  BoLA-T2b     2.2                                           
  BoLA-T2C     2.6                                           
  RSAEALFRL    490         498     BoLA-D18.4   1.2          
  BoLA-HD6     1.2                                           
  BoLA-T2a     1.9                                           
  BoLA-T2b     2.9                                           
  BoLA-T2C     2.7                                           
  ------------ ----------- ------- ------------ ------------ -----------------

[^1]: Guest Editor: Masha Fridkis-Hareli
